| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1375541-78-8 | tert-Butyl ((3S,5S,6R)-6-methyl-2-oxo-5-phenylpiperidin-3-yl)carbamate | C17H24N2O3 |
| 1375603-36-3 | alpha-[6,7-Bis(difluoromethoxy)-2-naphthalenyl]-alpha-(1-methylethyl)-1H-1,2,3-triazole-5-methanol | C18H17F4N3O3 |
| 1376043-30-9 | 4,5,6,7-Tetrahydro-2H-indazol-3-amine hydrochloride | C7H11N3.HCl |
| 1376099-80-7 | 3-(Aminomethyl)-1-piperazinecarboxylic acid 1,1-dimethylethyl ester | C10H21N3O2 |
| 1376292-07-7 | (3R)-2-Amino-1,3-butanediol | C4H11NO2 |
| 1376614-99-1 | (3S,4R)-1-(4-Fluorophenyl)-3-[(3R)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone | C24H21F2NO3 |
| 1376615-55-2 | Neratinib dimethylamine N-oxide | C30H29ClN6O4 |
| 1376615-91-6 | 8-Cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8h)-one | C24H31N7O2 |
| 1377049-84-7 | Velpatasvir | C49H54N8O8 |
| 1377239-83-2 | 2-(4-(Cyclohexylmethyl)piperazin-1-yl)-8-nitro-6-trifluoromethyl-4H-1,3-benzothiazin-4-one | C20H23F3N4O3S |
| 1377584-27-4 | Imidazo[1,5-a]pyrazine-1-carboxylic acid ethyl ester | C9H9N3O2 |
| 1377604-63-1 | Methyl [(1R)-2-[(2S,4S)-2-[5-[2-[(2S,5S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]-1,4,5,11-tetrahydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl]-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate | C49H56N8O8 |
| 1377838-24-8 | N-[2-[4-(1-Piperidinyl)phenyl]ethyl]carbamic acid 1,1-dimethylethyl ester | C18H28N2O2 |
| 1378387-81-5 | 1-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-2-chloroethanone | C15H8BrClF2O |
| 1378388-16-9 | (2S,4S)-4-(Methoxymethyl)-1,2-pyrrolidinedicarboxylic acid 1-(1,1-dimethylethyl) ester | C12H21NO5 |
| 1378388-19-2 | 7-[(2-Bromo-5-chlorophenyl)methoxy]-3,4-dihydro-1(2H)-naphthalenone | C17H14BrClO2 |
| 1378388-20-5 | 3-Chloro-10,11-dihydro-5H-benzo[d]naphtho[2,3-b]pyran-8(9H)-one | C17H13ClO2 |
| 1378388-22-7 | 9-Bromo-3-chloro-10,11-dihydro-5H-benzo[d]naphtho[2,3-b]pyran-8(9H)-one | C17H12BrClO2 |
| 1378388-35-2 | (3S,5S)-1-(tert-Butoxycarbonyl)-5-(methoxycarbonyl)pyrrolidine-3-carboxylic acid | C12H19NO6 |
| 1378390-29-4 | 3-(2-Bromoacetyl)-10,11-dihydro-5H-benzo[d]naphtho[2,3-b]pyran-8(9H)-one | C19H15BrO3 |
| 1378391-42-4 | (2S,4S)-4-(Methoxymethyl)-1,2-pyrrolidinedicarboxylic acid 2-[2-(9-bromo-8,9,10,11-tetrahydro-8-oxo-5H-benzo[d]naphtho[2,3-b]pyran-3-yl)-2-oxoethyl] 1-(1,1-dimethylethyl) ester | C31H34BrNO8 |
| 1378391-43-5 | 1-tert-Butyl 2-[2-[9-[[[(2S,5S)-1-[(S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]carbonyl]oxy]-8-oxo-8,9,10,11-tetrahydro-5H-dibenzo[c,g]chromen-3-yl]-2-oxoethyl] (2S,4S)-4-(methoxymethyl)pyrrolidine-1,2-dicarboxylate | C44H55N3O13 |
| 1378391-44-6 | tert-Butyl (2S,4S)-2-[5-[2-[(2S,5S)-1-[N-(methoxycarbonyl)-L-valyl]-5-methylpyrrolidin-2-yl]-1,4,5,11-tetrahydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl]-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate | C44H55N7O7 |
| 1378391-45-7 | (2S,4S)-2-[5-[1,11-Dihydro-2-[(2S,5S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-5-methyl-2-pyrrolidinyl][2]benzopyrano[4',3':6,7]naphth[1,2-d]imidazol-9-yl]-1H-imidazol-2-yl]-4-(methoxymethyl)-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester | C44H53N7O7 |
| 1378391-86-6 | (2S,4S)-2-(5-Iodo-1H-imidazol-2-yl)-4-(methoxymethyl)-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester | C14H22IN3O3 |
| 1378392-94-9 | tert-Butyl (2S,5S)-2-(9-chloro-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-(methyl)pyrrolidine-1-carboxylate | C28H28ClN3O3 |
| 1378392-96-1 | Methyl [(2S)-1-[(2S,5S)-2-[9-chloro-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2-yl]-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate | C30H31ClN4O4 |
| 1378392-97-2 | Methyl [(2S)-3-methyl-1-[(2S,5S)-2-methyl-5-[9-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2-yl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamate | C36H43BN4O6 |
| 1378466-25-1 | Vigabatrin EP Impurity E | C7H11NO4 |
| 1378524-41-4 | N-[(2E)-3-(2-Fluorophenyl)-2-methyl-2-propen-1-yl]-3,4,5-trimethoxy-N-[2-(1-methyl-2-pyrrolidinyl)ethyl]benzamide | C27H35FN2O4 |
| 1378598-49-2 | 6-Fluoro-5-nitro-3-pyridinecarbonitrile | C6H2FN3O2 |
| 1378655-77-6 | Methyl 2-fluoro-5-hydroxy-4-methylbenzoate | C9H9FO3 |
| 1378821-66-9 | 6-Azabicyclo[3.2.1]octan-3-one hydrochloride (1:1) | C7H11NO.HCl |
| 1378874-22-6 | Methyl 2-amino-3-bromo-5-methoxybenzoate | C9H10BrNO3 |
| 1378888-43-7 | 1-(3-Ethyl-4-hydroxymethyl-phenyl)ethanone | C11H14O2 |
| 1378955-81-7 | 4-Amino-3-(hydroxymethyl)benzoic acid | C8H9NO3 |
| 1379005-34-1 | N-Acetyl-N-[2-(7-methoxy-1-naphthalenyl)ethyl]acetamide | C17H19NO3 |
| 1379192-95-6 | 3-Fluoro-4-(2-morpholinyl)benzenamine | C10H13FN2O |
| 1379220-74-2 | 2,4-Difluoro-6-methylbenzenemethanol | C8H8F2O |
| 1379260-15-7 | 5-Chloro-4-hydroxy-1-methyl-2(1H)-pyridinone | C6H6ClNO2 |
| 1379262-63-1 | 4-(1-Methylcyclopropyl)benzonitrile | C11H11N |
| 1379324-09-0 | 4,6-Dichloro-N-methyl-2-pyridinecarboxamide | C7H6Cl2N2O |
| 1379326-84-7 | 6-Bromo-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (1:1) | C10H12BrN.HCl |
| 1379334-58-3 | 4-Oxo-4H-thieno[3,2-d][1,3]oxazine-2-carboxylic acid methyl ester | C8H5NO4S |
| 1379337-32-2 | N-[2-(Aminocarbonyl)-1H-pyrrol-1-yl]carbamic acid ethyl ester | C8H11N3O3 |
| 1379341-19-1 | 3-Chloro-5-fluoro-2-methylbenzoic acid methyl ester | C9H8ClFO2 |
| 1379358-48-1 | 6-Bromoimidazo[1,2-a]pyridin-8-ol hydrochloride (1:1) | C7H5BrN2O.HCl |
| 1379365-61-3 | 4-Amino-5-bromo-2,3-difluorobenzoic acid | C7H4BrF2NO2 |
| 1379378-74-1 | 6-Bromo-2,3,4,5-tetrahydro-1H-3-benzazepine | C10H12BrN |
| 1379403-11-8 | Vigabatrin EP Impurity B (HCl) | C6H12ClNO2 |